Latest Breaking News On - Zentalis pharmaceuticals price performance - Page 1 : comparemela.com

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has been given an average rating of “Moderate Buy” by the seven ratings firms that are currently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year […]

Melissab epperlyInsider transactions at zentalis pharmaceuticalsDecheng capitalZentalis pharmaceuticals price performanceInstitutional investors weigh in on zentalis pharmaceuticalsNews ratings for zentalis pharmaceuticals dailyVanguard group incRafferty asset managementZentalis pharmaceuticals incHermes incAnalyst recommendations for zentalis pharmaceuticalsZentalis pharmaceuticalsEventide asset managementGet free reportMarketbeat ratingsAsset management